Publications


Developments of mass spectrometry-based technologies for effective drug development linked with clinical proteomes.
Drug Metab Pharmacokinet 2016 Feb 17;31(1):3-11. Epub 2015 Dec 17.
Biosys Technologies, Inc., Meguro-ku, Tokyo, Japan; Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan; Center of Excellence in Biological and Medical Mass Spectrometry, Lund University, BMC, Lund, Sweden.

An improvement on mass spectrometry-based epigenetic analysis of large histone-derived peptides by using the Ionization Variable Unit interface.
Anal Biochem 2015 Oct 5;486:14-6. Epub 2015 Jun 5.
Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Meguro-Ku, Tokyo 153-8904, Japan. Electronic address:

Drug compound characterization by mass spectrometry imaging in cancer tissue.
Arch Pharm Res 2015 Sep 23;38(9):1718-27. Epub 2015 Jul 23.
Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, BMC D13, Lund, Sweden.



A protein deep sequencing evaluation of metastatic melanoma tissues.
PLoS One 2015 13;10(4):e0123661. Epub 2015 Apr 13.
Centre of Excellence in Biological and Medical Mass Spectrometry "CEBMMS", Biomedical Centre D13, Lund University, Lund, Sweden; Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, Lund, Sweden; First Dept. of Surgery, Tokyo Medical University, Tokyo, Japan.

Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories.
Clin Transl Med 2014 Dec 22;3(1):61. Epub 2014 Nov 22.
First Department of Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku Shinjuku-ku, Tokyo, 160-0023 Japan ; Clinical Protein Science & Imaging, Biomedical Center, Dept. of Biomedical Engineering, Lund University, BMC D13, 221 84 Lund, Sweden ; Center of Excellence in Biological and Medical mass spectrometry (CEBMMS), 221 84 Lund, Sweden.




Standard guidelines for the chromosome-centric human proteome project.
J Proteome Res 2012 Apr 26;11(4):2005-13. Epub 2012 Mar 26.
Yonsei Proteome Research Center and Department of Integrated Omics for Biomedical Science, World Class University Program, Yonsei University, Seoul, Korea.








Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma.
Clin Cancer Res 2007 Feb;13(3):799-805
Proteome Bioinformatics Project, National Cancer Center Research Institute, Department of Surgery, Tokyo Medical University, and Clinical Laboratory Division, National Cancer Center Hospital, Japan.

Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis.
Biochem Biophys Res Commun 2004 May;318(2):461-9
Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

OF